COLORADO SPRINGS, Colo., Oct. 16, 2019 /PRNewswire/ -- Pharmaceutical CBD (cannabidiol) is now more widely accessible than ever before with the acquisition of an Active Pharmaceutical Ingredient (API) License for CBD Isolate by CBD giant

NORTHBROOK, Ill., Oct. 16, 2019 /PRNewswire/ -- The U.S. Department of Veteran Affairs (VA) and 

RICHMOND, Va., Oct. 16, 2019 /PRNewswire/ -- The fastest-rising long term care costs are no longer for the most skilled care – in a facility, they're now for the least-complex care – at home, according to Genworth's latest 2019 Cost of Care Survey results, announced today.Experience the interactive Multichannel News Release here:

INDIANAPOLIS, Oct. 16, 2019 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced top-line results from its Phase 3 SEQUOIA trial evaluating pegilodecakin plus FOLFOX (folinic acid, 5-FU, oxaliplatin) compared to FOLFOX alone in patients with metastatic pancreatic cancer whose disease had progressed during or following a first-line gemcitabine-containing regi

Sherbrooke facility to reach annual run-rate of 200,000 kg by the end of November LAVAL, QC, Oct. 16, 2019 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT) is pleased to announce that its Sherbrooke, Quebec facility started to pro

DENVER, Oct. 16, 2019 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that it has been recognized by the

SAN DIEGO, Oct. 16, 2019 /PRNewswire/ -- Insilico Medicine and ChemDiv, Inc. launched a new strategic collaboration to provide certain pharmaceutical and biotechnology companies with end-to-end drug discovery solutions. This collaboration combines the most advanced artificial intelligence (AI) techniques with a premium integrated drug discovery shared risk platform. The

SAN FRANCISCO, Oct. 16, 2019 /PRNewswire/ -- Today, CleanFund Commercial PACE Capital, Inc. ("CleanFund") announced funding $36 million in Commercial Property Assessed Cle

ALPHARETTA, Ga., Oct. 16, 2019 /PRNewswire/ -- Leading medical education consortium xMedica LLC is pleased to announce a new and expanded educational website featuring CME and non-CME programs for aesthe

SHANGHAI, Oct. 16, 2019 /PRNewswire/ -- Hepagene Therapeutics, Inc, a clinical stage drug discovery and development company which devotes its efforts towards discovering, developing and delivering innovative medicines that help patients prevail over liver diseases, announced today that it has dosed the first healthy volunteer in a phase I clinical trial of HPG1860 in